<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02731755</url>
  </required_header>
  <id_info>
    <org_study_id>PROGRAIN2</org_study_id>
    <nct_id>NCT02731755</nct_id>
  </id_info>
  <brief_title>Phenolic-rich Oats for Gut-bacteria Relief and Artery Improvement</brief_title>
  <acronym>PROGRAIN2</acronym>
  <official_title>Acute Cardiovascular Effects of Phenolic Rich Oats in Men With Above Average Blood Pressure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Reading</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Biotechnology and Biological Sciences Research Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rothamsted Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>PepsiCo Global R&amp;D</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Roehampton</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Reading</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A diet rich in whole grain is inversely associated with cardiovascular disease risk. Whole
      grains contain a wide range dietary components including potentially vasoactive phenolic
      acids. In this proposed human trial, the investigators aim to establish whether consumption
      of one portion of phenolic acid-rich oats leads to acute improvements (i.e. 1-24h
      post-intake) in markers of cardiovascular disease risk relative to an energy matched control
      intervention in healthy men with high-normal to mildly elevated blood pressure.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Flow mediated dilatation</measure>
    <time_frame>Acute postprandial timecourse from Baseline, 1hour to 24hours</time_frame>
    <description>Technique to assess the flexibility of the endothelium in larger peripheral blood vessels, magnitude of increase in percentage from baseline to 24h</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Laser Doppler Iontophoresis</measure>
    <time_frame>Acute postprandial timecourse from Baseline, 2hours to 24hours.</time_frame>
    <description>Magnitude of increase from Baseline to 24h</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phenolic acids metabolites</measure>
    <time_frame>Acute postprandial timecourse from Baseline, 1hour to 24hours.</time_frame>
    <description>Concentration of phenolic acid metabolites in plasma and urine as Assessed by liquid chromatography/mass spectrometry magnitude of increase in AUC from Baseline to 24h</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma nitric oxide analysis</measure>
    <time_frame>Acute postprandial timecourse from Baseline, 1hour to 24hours.</time_frame>
    <description>Concentration of nitric oxide in nmol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NADPH oxidase activity in neutrophil blood cells</measure>
    <time_frame>Acute postprandial timecourse from Baseline, 1hour to 24hours.</time_frame>
    <description>NADPH oxidase activity will be calculated as the difference between values obtained in PMA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma glucose</measure>
    <time_frame>Acute postprandial timecourse from Baseline, 1hour to 24hours.</time_frame>
    <description>Glucose concentration in mmol/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma insulin</measure>
    <time_frame>Acute postprandial timecourse from Baseline, 1hour to 24hours.</time_frame>
    <description>Insulin concentration in pmol/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renin activity</measure>
    <time_frame>Acute postprandial timecourse from Baseline, 1hour to 24hours.</time_frame>
    <description>Renin activity in ng/(mL*hour)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Oat intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>66.8g instant oatmeal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>60g cream of rice</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oat</intervention_name>
    <description>The study oat intervention products will consist of porridge containing 66.8g flaked oats.</description>
    <arm_group_label>Oat intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>60g cream of rice</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Above average blood pressure (i.e. systolic 120-159 mmHg and diastolic 80-99 mmHg)

        Exclusion Criteria:

          -  Abnormal biochemical, haematological results as assessed at health screening

          -  Hypertension (i.e. systolic/diastolic blood pressure ≥160/100 mm Hg) BMI &gt;35

          -  Current smoker or ex-smoker ceasing &lt;3 months ago

          -  Past or existing medical history of vascular disease, diabetes, hepatic, renal,
             gastrointestinal, haematological, neurological, thyroidal disease or cancer

          -  Prescribed or taking lipid lowering, antihypertensive, vasoactive (e.g. Viagra),
             anti-inflammatory, antibiotic or antidepressant medication

          -  Allergies to whole grains

          -  Parallel participation in another research project

          -  Having flu vaccination or antibiotics within 3 months of trial start

          -  On a weight reduction regime or taking food supplements within 3 months of trial start

          -  Performing high level of physical activity (i.e. &gt;3 x 20 min aerobic exercise/week)

          -  Consumption of ≥21 units of alcohol/week

          -  Small veins not allowing cannulation
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeremy P Spencer, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Reading</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jeremy P Spencer, Professor</last_name>
    <phone>+44 (0) 118 378 8724</phone>
    <phone_ext>8724</phone_ext>
    <email>j.p.e.spencer@rdg.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Manuel Y Schar, PDRA</last_name>
    <phone>+44 (0) 1183786394</phone>
    <email>m.y.schar@reading.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hugh Sinclair Unit of Human Nutrition</name>
      <address>
        <city>Reading</city>
        <state>Berkshire</state>
        <zip>RG6 6AP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeremy P Spencer, PhD</last_name>
      <phone>+44(0)1183788724</phone>
      <email>j.p.spencer@reading.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Jeremy P Spencer, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hugh Sinclair Unit of Human Nutrition</name>
      <address>
        <city>Reading</city>
        <zip>RG66AP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Hargreaves, Unit Manager</last_name>
      <phone>0118 378 7771</phone>
      <email>s.e.hargreaves@reading.ac.uk</email>
    </contact>
    <contact_backup>
      <last_name>Angelika Kristek, Research assistant</last_name>
      <phone>0118 378 7771</phone>
      <email>a.kristek@reading.ac.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Jeremy Spencer, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2016</study_first_submitted>
  <study_first_submitted_qc>April 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2016</study_first_posted>
  <last_update_submitted>October 6, 2016</last_update_submitted>
  <last_update_submitted_qc>October 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Reading</investigator_affiliation>
    <investigator_full_name>Jeremy Paul Edward Spencer</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Oats</keyword>
  <keyword>Phenolic acid</keyword>
  <keyword>FMD</keyword>
  <keyword>LDI</keyword>
  <keyword>Renin angiotensin</keyword>
  <keyword>Nitric oxide</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Publish</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

